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In modern society, a potentially serious adverse event attributed 
to a vaccination is likely to be snapped up by the media, particu-
larly newspapers and television, as it appeals to the emotions of 
the public. The widespread news of the alleged adverse events 
of vaccination has helped to create the “urban myth” that vac-
cines cause serious neurological disorders and has boosted anti-
vaccination associations. This speculation is linked to the fact 
that the true causes of many neurological diseases are largely 
unknown. The relationship between vaccinations and the onset of 
serious neuropsychiatric diseases is certainly one of coincidence 
rather than causality. This claim results from controlled studies 
that have excluded the association between vaccines and severe 
neurological diseases, therefore it can be said, with little risk of 
error, that the association between modern vaccinations and seri-
ous neurological disorders is a true “urban myth”.
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Summary
Introduction
Many severe neuropsychiatric diseases, such as Alzhei-
mer’s disease, multiple sclerosis, autism, epilepsy, schizo-
phrenia, encephalomyelitis, encephalopathies, transverse 
myelitis and optic neuritis, do not yet have a well-defined 
etiopathogenesis, although important progress has been 
made on their causes. Several studies have shown that 
these diseases are due both to genetic factors (intrinsic 
factors) and environmental factors (extrinsic factors). 
With regard to autism spectrum disorders, for example, as 
early as 1977 Folstein and Rutter published the first study 
of twins and autism focusing on genetic aspects, which 
showed that the concordance rate in monozygotic twins 
was much higher than in fraternal twins [1]. Incomplete 
understanding of the causes of the above diseases has 
sometimes led to the belief that they are caused by vacci-
nations; in reality, however, the relationship between vac-
cinations and the onset of serious neuropsychiatric dis-
eases is certainly one of coincidence rather than causality.
In modern society, a potentially serious adverse event 
attributed to a vaccination is likely to be snapped up 
by the media, particularly newspapers and television, 
as it appeals to the emotions of the public. Indeed, a 
“good” item of news is one that arouses fear or hope. 
Thus, for example, considerable attention was devoted 
to the publication of Andrew Wakefield’s article, which 
linked measles vaccination to pervasive developmental 
disorders and non-specific colitis [2], and to the case of 
Heather Whitestone, who was elected Miss America de-
spite her deafness, which had erroneously been attrib-
uted to the diphtheria, tetanus and pertussis vaccine [3]. 
The widespread news of the alleged adverse events of 
vaccination has helped to create the “urban myth” that 
vaccines cause serious neurological disorders and has 
boosted anti-vaccination associations. These associa-
tions can be traced back to the nineteenth century, with 
the foundation of the National Anti-Vaccination League 
in 1896 in Britain and the Anti-Vaccination Society of 
America in 1879 in the US [4]. By the end of the twenti-
eth century, opposition to vaccinations had strengthened 
in most developed countries because diseases preventa-
ble by vaccinations had become increasingly rare. Thus, 
with regard to the subject of vaccinations, the ethical, 
social, religious and legal issues cannot be ignored.
Neurological diseases without a well-
defined etiopathogenesis
a) Alzheimer’s disease. Alzheimer’s disease (AD) is the 
most common form of dementia among older people. 
AD begins slowly, first involving those parts of the 
brain that control thought, memory and language. 
People with AD may have trouble remembering 
things that happened recently or the names of people 
they know. Over time, the symptoms worsen; suffer-
ers may no longer recognize family members or have 
difficulty speaking, reading or writing. Subsequently, 
they may become anxious or aggressive, or wander 
away from home. Eventually, they need total care [5]. 
Scientists do not yet fully understand what causes Alz-
heimer’s disease, but it has become increasingly clear 
that it develops because of a complex series of events 
that take place in the brain over a long period of time. 
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It is likely that the causes include some mix of genetic, 
environmental and lifestyle factors [6].
b) Autism. The autism spectrum disorders are develop-
mental disabilities, which debut during childhood. 
Their clinical presentation is characterized by disor-
ders in social and communication relationships with 
others and by repetitive, stereotyped behaviors  [7]. 
Although the causes of autism are not yet fully under-
stood, it is certain that genetic factors are involved. 
However, the genetics of the disorder is extremely 
complex; indeed, a recent study has shown that at 
least 127 genes are involved [8]. Moreover, extrinsic 
causes would act only during pregnancy [9].
c) Encephalomyelitis. Acute disseminated encephalo-
myelitis (ADEM) is an immune-mediated inflam-
matory demyelinating state, which mainly affects 
the white substance of the neuraxis. The disease 
manifests itself as an acute onset encephalopathy 
combined with multiple neurological deficits, and is 
typically self-limiting [10-12]. ADEM usually devel-
ops after viral or bacterial infection and, in the past, 
it could develop after vaccination against rabies or 
smallpox; in some patients, however, the cause re-
mains unknown. Many infectious agents have been 
linked to ADEM, including chickenpox, mumps, 
measles, rubella, influenza, coxsackievirus B, herpes 
simplex virus, Legionella, Campylobacter, Borrelia 
burgdorferi, Salmonella typhi, Mycoplasma pneu-
moniae, Chlamydia pneumoniae, etc. [13].
d) Encephalopathies. The term encephalopathy indicates 
any widespread disease of the brain that alters the 
function or structure of the brain. Encephalopathy can 
be caused by an infectious agent (bacteria, viruses, or 
prions), by a mitochondrial or metabolic dysfunction, 
brain tumors or increased pressure in the skull, pro-
longed exposure to toxic elements (including solvents, 
drugs, radiation, paints, industrial chemicals and cer-
tain metals), chronic trauma, poor nutrition, or lack of 
oxygen or blood flow to the brain. The hallmark of 
encephalopathy is an altered mental state. Depending 
on the type and severity of the encephalopathy, the 
most common neurological symptoms are progressive 
memory loss and the deterioration of cognitive abili-
ties, inability to concentrate, lethargy, and the gradual 
loss of consciousness [14].
e) Epilepsy. Epilepsy is a disorder of the central nervous 
system in which the activity of nerve cells in the brain is 
interrupted, causing seizures or periods of unusual be-
havior, strange sensations and sometimes loss of con-
sciousness. Symptoms may include confusion, tempo-
rary absence and involuntary movements of the arms 
and legs. These symptoms may be associated to psy-
chological symptoms. In about half of cases, epilepsy 
does not have an identifiable cause; in the other half, 
the condition can be attributed to various factors. The 
genetic influence seems to be very important. Indeed, 
some researchers have estimated that in 70% of cases 
there is a genetic influence, and that more than 500 
genes may be linked to the condition [15]. Head trau-
ma, brain tumors, stroke and some infectious diseases, 
such as AIDS, can cause epilepsy. Even prenatal injury, 
caused by an infection in the mother, malnutrition or 
oxygen deficiency, for example, may be involved. Epi-
lepsy can sometimes be associated to developmental 
disorders, such as autism and neurofibromatosis.
f) Optic neuritis. Optic neuritis is a condition charac-
terized by inflammation of the optic nerve. While it 
may be associated to a variety of systemic autoim-
mune diseases, the most common form is best known 
for its association to multiple sclerosis [16]. Recur-
rence of optic neuritis after a single, isolated incident 
is not uncommon  [17]. Patients report sub-acute 
visual loss and difficulty in seeing colors, especially 
red, which appears faded. Pain on eye movement is 
often present. Visual loss is usually monocular, but 
may involve both eyes, and generally reaches its 
peak within hours or days. The majority of patients 
recover their visual acuity.
g) Schizophrenia. Schizophrenia is a debilitating mental 
illness that affects 1% of the population worldwide. 
Schizophrenia is characterized by positive and nega-
tive symptoms. The former include hallucinations 
and voices that speak to the patient; the latter include 
loss of the sense of pleasure, loss of will and social 
isolation  [18]. A family history of schizophrenia is 
the main risk factor [19]. Other hypothetical risk fac-
tors include: the season and place of birth, socioeco-
nomic status and maternal infections  [20]. Schizo-
phrenia appears to be a polygenic disorder which can 
be influenced by environmental factors [21].
h) Transverse myelitis. Transverse myelitis is a neuro-
logical disorder caused by bilateral inflammation of 
a level, or segment, of the spinal cord. This inflam-
mation damages myelin, disrupting communications 
between the nerves of the spinal cord and the rest 
of the body. The symptoms of transverse myelitis 
include a loss of spinal cord function for several 
days or weeks. The onset is characterized by a sud-
den back pain, muscle weakness, or abnormal sensa-
tions in the fingers and toes. The disease can rapidly 
progress, causing more severe symptoms, including 
paralysis, urinary retention and loss of sphincter con-
trol. Although some patients recover and are left with 
minor damage or no residual problems, others suf-
fer permanent disabilities that affect their capacity to 
perform normal everyday activities. Researchers are 
uncertain of the exact causes of transverse myelitis. 
The inflammation which causes such extensive dam-
age to the nerve fibers of the spinal cord can result 
from viral infections or abnormal immune reactions. 
Transverse myelitis may also occur as a complica-
tion of syphilis, measles and Lyme disease [22].
Causality or casualness?
Alzheimer’s disease
An “urban myth” concerning the association between in-
fluenza vaccination and Alzheimer’s disease was created 
in 2005 after an episode of the television show “Larry 
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King Live” in which Bill Maher was being interviewed by 
Larry King. Maher argued that “if you have a flu shot for 
more than five years in a row, there’s ten times the likeli-
hood that you’ll get Alzheimer’s disease” [23]. Dr. Maher 
was referring to Dr. Hugh Fudenberg’s speech during the 
1st annual International Public Conference on Vaccina-
tion, held by the National Vaccine Information Center in 
Arlington, Virginia in 1997 [24]. However, a study con-
ducted by Verreault et al. in 2001 refuted Maher’s claim. 
Indeed, by means of a prospective study – the “Canadian 
Study on Health and Aging”, a cohort Study on demen-
tia – Verreault et al. had shown that increased exposure 
to vaccines against diphtheria, tetanus, polio and flu not 
only was not a risk of contracting Alzheimer’s, but could 
actually protect against the disease [25].
Autism
Regarding Mumps/Measles/Rubella (MMR) vaccines, 
the British Medical Journal [26] defined the main study 
that linked these vaccines to autism as a “deliberate 
fraud”. This conclusion resulted from an investigation 
conducted by the investigative journalist Brian Deer 
into the research originally published in 1998 by the 
journal the Lancet, before being withdrawn in February 
2010  [2]. The paper had associated the administration 
of MMR vaccine with a new syndrome characterized by 
autism and ileal lymphoid hyperplasia associated to non-
specific colitis. According to Fiona Godlee, the editor in 
chief of the BMJ, the article by Wakefield “was based 
not on bad science but on a deliberate fraud” [26]. In her 
editorial, published in 2011, Godlee pointed out that in 
Wakefield’s research: 
•	 only one of the nine children who allegedly had au-
tism really did;
•	 five of the children had developmental difficulties 
before vaccination, although the article claimed that 
all were in good health before vaccination.
•	 Although the paper claimed that a mean time of 6.3 
days elapsed between vaccination and the onset of 
symptoms, some children who had their first symp-
toms months after vaccination. Furthermore, many 
studies carried out after the publication of the paper 
by Wakefield et al. demonstrated without any doubt 
that MMR vaccines do not engender a higher risk of 
autism or colitis [27-30]. The US Institute of Medi-
cine (IOM) also concluded that “The evidence favors 
rejection of a causal relationship between MMR vac-
cine and autism” [31].
Acute Disseminated Encephalomyelitis 
(ADEM), Encephalitis and Encephalopathies
With regard to encephalitis, it is necessary to distinguish 
between acute disseminated encephalomyelitis (ADEM), 
encephalitis and encephalopathy. Some neurology texts 
state that ADEM may be caused by vaccines. Actually, 
this association is linked mainly to the fact that the old 
vaccines against rabies, which were derived from animal 
nerve tissue (NTV), namely Fermi and Semple vaccines, 
could lead to sensitization, not least because of the high 
number of doses required for post-exposure prophylaxis. 
However, these vaccines have not been used in industri-
alized countries since the 1970s, and the World Health 
Organization (WHO) effectively banned them in 1992. 
The incidence of neurological Serious Adverse Events 
(SAE) after administration of rabies NTV varied widely: 
from 1 per 230 to 1 per 6,000 vaccinations [32]. In the 
case of smallpox vaccines, too, post-vaccination en-
cephalopathies and encephalitis were well-known, albeit 
very rare, adverse events (about 1 case per 665,000 vac-
cinees in the US and 1 case per 345,000 in Italy) [33]. 
However, as smallpox has been eradicated, smallpox 
vaccines are no longer used. Subsequently, neurological 
SAE were attributed to several vaccines, namely: MMR, 
varicella, influenza, hepatitis A and B, papillomavirus, 
diphtheria-tetanus-pertussis and menC conjugate vac-
cines. Regarding the hypothesis that MMR vaccine 
causes a risk of encephalitis, Duclos et al. estimated an 
incidence of 1 case per million recipients [34], and stud-
ies conducted in Albania [35], Finland [36], the US [37], 
Great Britain and Ireland [38] suggested that there was 
no link between MMR vaccine and encephalitis. Indeed, 
in 2011 the Institute of Medicine concluded that “The 
evidence is inadequate to accept or reject a causal rela-
tionship between MMR vaccine and encephalitis” [31].
In addition, adverse events such as encephalitis and en-
cephalopathy have been reported after the administra-
tion of influenza vaccines. Although there are reports 
(case reports) of encephalitis or encephalopathy after the 
administration of flu vaccines  [39,  40], the controlled 
studies reported in the literature do not demonstrate a 
causal association with either inactivated vaccines (TIV) 
or live attenuated vaccines [41-43]. In this regard, Lee et 
al. conducted a study on the safety of both the monova-
lent pandemic vaccine containing the virus H1n1pdm09 
and the seasonal vaccine administered separately in the 
2009-10 flu season. Having investigated over 1,345,663 
individuals who had received the monovalent inactivat-
ed pandemic vaccine; 267,715 individuals who had been 
vaccinated with the live attenuated pandemic vaccine; 
2,741,150 subjects vaccinated with the seasonal inacti-
vated vaccine, and 157,838 recipients of the seasonal live 
attenuated vaccine, the authors found non-significant as-
sociations between the vaccines and Guillain-Barré syn-
drome and other major neurological diseases [44].
With regard to the possible association between the vac-
cine against hepatitis B and encephalitis or encephalop-
athy, after analyzing the literature the IOM concluded 
that, from the epidemiological standpoint, there was no 
evidence of a possible causal association [45, 46].
As for the hypothetical association between encephali-
tis / encephalopathy and the Tdap vaccine, the only two 
controlled studies considered by the IOM reached con-
flicting conclusions, but both displayed methodologi-
cal limitations. Moreover, a study conducted in Italy by 
Greco et al. [47] was refuted by later research [48]. In 
addition, a study conducted by Yih et al. [49] on 660,000 
patients, within the network of the Vaccine Safety Data-
link, found a lower risk of encephalopathy (0.84) in pa-
tients who received the Tdap vaccine than in the control 
group. Another study by Ray et al. found a lack of evi-
R. GASPARINI et Al.
E4
dence of an association between Tdap vaccine or MMR 
vaccine and encephalitis or encephalopathy [50].
It has also been speculated that the conjugate vaccine 
against meningitis C could cause encephalitis or en-
cephalopathy. However, a controlled study conducted 
by Ward et al. [51] found no causal association between 
this vaccine and any type of encephalopathy. Safety in-
dications, which also exclude associations between the 
meningococcal tetravalent conjugate vaccine and en-
cephalopathies, were suggested by large studies [52-54].
In 2000, Creutzfeld Jacobs Disease (CJD), a progres-
sive degenerative disease of the central nervous system, 
was diagnosed in 73 subjects in England. This disease 
is caused by infectious proteins, called prions, and can 
be acquired by consuming the meat of animals affected 
by “mad cow disease”. Since small amounts of bovine 
serum and gelatin were used to prepare the vaccines ob-
tained from cell culture, it was erroneously assumed that 
these vaccines were capable of transmitting CJD. How-
ever, the probability that the vaccines contained prions 
was, in fact, nil. Indeed, prions have never been found 
in the serum or connective tissue of cattle with bovine 
spongiform encephalopathy (BSE); bovine serum is pre-
sent in low concentrations in the cell cultures used to 
prepare vaccines; prions do not multiply in cell cultures 
in vitro and, finally, CJD is transmitted to humans only 
by eating meat contaminated with prions [32].
Multiple sclerosis
In 1991, an article by Herroelen et al. [55] published in 
the Lancet reported the onset of multiple sclerosis six 
weeks after the administration of DNA-recombinant 
vaccine against hepatitis B. Although subsequent studies 
found no association between the vaccine and multiple 
sclerosis [56], the report aroused considerable mistrust 
of this vaccine in France, where vaccination coverage 
(86%) at the age of 6 months is still insufficient [57]. By 
contrast, in Italy, where vaccination is mandatory for all 
new-borns, coverage with 3 doses at 24 months stands 
at 95.3% [58]. 
Epilepsy
In 1974, Kulenkampff et al. published a study on an un-
controlled case series which reported mental retardation 
and epilepsy in children who had received the whole-
cell whooping cough vaccine [59]. This study was wide-
ly publicized by the mass media, resulting in widespread 
mistrust of the pertussis vaccine in Britain; subsequently, 
coverage fell drastically from 83% to 31%. As a result, 
more than 100,000 cases of pertussis and 36 avoidable 
deaths occurred in Britain [60]. Similarly, decreased im-
munization rates and increased deaths due to pertussis 
were also seen in Japan, where pertussis vaccination was 
temporarily suspended. In this country, the proportion of 
children immunized dropped from 70% to 20%, while 
cases of pertussis increased from 393 (0 deaths) in 1974 
to 13,000 (41 deaths) in 1979 [61]. Subsequently, excel-
lent well-controlled studies demonstrated that there was 
no difference in the rates of mental retardation and epi-
lepsy between children who had been vaccinated against 
pertussis and those who had not [45, 62].
As for the hypothesis that vaccinations, or some of them 
at least, may be increase the risk of epilepsy, it should 
be pointed out that only the vaccine against MMR in-
duces a statistically significant increased risk of febrile 
seizures  [63,  64]. With regard to varicella, hepatitis, 
diphtheria, tetanus and pertussis, there is no evidence of 
a correlation between vaccines and febrile seizures [31]. 
Moreover, the literature suggests that there is no epide-
miological evidence of an association between flu vac-
cines and febrile seizures [41, 42, 65]. However, the risk 
of febrile seizures is not associated with a major risk of 
epilepsy [31]. As for the association between MMR vac-
cines and afebrile seizures, there is evidence of a null 
association [31].
The hypothesis of a potential link between MMR vac-
cine and epilepsy was investigated in 2004 by Vester-
garden et al. [66], who considered a sample of 439,251 
Danish children. They concluded that there was no evi-
dence of an increased risk of epilepsy in children vacci-
nated with MMR, since their study, which had involved 
a large sample of subjects, did not find any different in 
the incidence of epilepsy between vaccinated and unvac-
cinated children. Furthermore, next-generation sequenc-
ing technologies have markedly increased the speed of 
gene discovery in monogenic epilepsies, allowing us to 
recognize a genetic cause of the disease in a growing 
number of patients and improving our understanding of 
its underlying pathophysiology [67].
Advances in the field of genetics have revealed how 
misguided it is to attribute serious neurological adverse 
events to vaccinations. In this perspective, Reyes et al. 
published a very enlightening article entitled: “Alleged 
cases of vaccine encephalopathy re-diagnosed years 
later as Dravet Syndrome”. In this paper, the authors 
reported that, in five subjects with encephalopathy pre-
viously attributed to the pertussis vaccine, subsequent 
genetic investigations revealed Dravet’s syndrome, a 
rare epileptic encephalopathy known to be linked to mu-
tations in the SCN1A (neuronal sodium channel alpha1 
subunit) [68].
Optic neuritis
•	 MMR, influenza, hepatitis B and DTap vaccines 
have been suspected of involvement in optic neuri-
tis. With regard to the association of MMR vacci-
nation with optic neuritis, only one paper on a con-
trolled study has been published [69]. In this study, 
the authors compared 108 cases from three HMOs 
participating in the VSD (Vaccine Safety datalink) 
with 228 controls. The conclusion was that MMR 
vaccination did not increase the risk of optic neuritis. 
Having examined this study and also considering its 
limitations, the IOM concluded that: “The evidence 
is inadequate to accept or reject a causal relationship 
between MMR vaccine and optic neuritis” [31]. Re-
garding influenza vaccination and optic neuritis risk, 
several papers have reported single cases of the dis-
order after vaccine administration  [70-74]. Howev-
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er, while case-reports must be regarded as an alarm 
signal, they do not scientifically demonstrate a cor-
relation. The IOM also evaluated 2 controlled stud-
ies [69, 75]; these did not reveal a higher risk among 
recipients of influenza vaccine than among controls. 
However, after considering the limitations of these 
studies, the IOM concluded that: “The evidence is 
inadequate to accept or reject a causal relationship 
between influenza vaccine and optic neuritis”  [31]. 
Furthermore, a survey carried out in China after the 
administration of 89.6 million doses of influenza A 
H1N1pdm09 vaccine during September 2009 and 
March 2010 recorded only 3 cases of optic neuritis; 
the corresponding morbidity rate was 0.003 cases 
per 100,000 inhabitants, while the morbidity of optic 
neuritis in Singapore in 2009 was 0.89 per 100,000 
people  [76]. In addition, no cases of optic neuritis 
were reported to the US passive surveillance system 
(VAERS) in the period 2009-10 [77].
•	 Concerning the risk of optic neuritis in adults after 
the administration of hepatitis B vaccine, the litera-
ture reports two controlled studies: one by DeSte-
fano  [69] and one by Payne  [75]. The conclusions 
of both studies were that hepatitis B vaccination did 
not appear to be associated with an increased risk of 
optic neuritis in adults. Regarding mechanistic evi-
dence, several case-report studies are available in the 
literature; for the most part, however, these provided 
only temporal evidence [78-80]. 
•	 A study conducted by Roussat et al. in children found 
that a presumed trigger for optic neuritis could be 
suspected in 7 of the 20 children studied: five viral 
infections and two recent administrations of recom-
binant hepatitis B vaccine. However, the authors con-
cluded that it was very difficult to establish a causal 
association between the vaccinations and optic neu-
ritis in infants [81]. With regard to the hypothesized 
association between optic neuritis and vaccines con-
taining diphtheria and tetanus toxoids or antigens of 
Bordetella pertussis, in 2011 the IOM concluded, on 
the basis of a single controlled study [69] and a single 
case report [82], that: “The evidence was inadequate 
to accept or reject a causal relationship between 
diphtheria and tetanus toxoid-, or acellular pertussis-
containing vaccine and optic neuritis” [31].
Schizophrenia
On the relationship between vaccines and schizophre-
nia, some scholars have speculated that vaccines ad-
ministered during pregnancy may pose a risk for the 
unborn child. Although no epidemiological studies have 
shown the existence of a causal link, some authors, such 
as Russell Blaylock, have described a theoretical risk. 
He claims that immune cytokines (IL-1, IL-2, Il-8, IL-6 
and TNF-alpha) can cause injury to the baby’s develop-
ing brain, and that excessive immune stimulation during 
pregnancy could give rise to autism and other pervasive 
neurological disorders, including schizophrenia [83-85].
Although experiments on animal models have docu-
mented problems of brain development in baby mice 
born to mothers infected with influenza viruses, this 
does not demonstrate an association with flu vaccina-
tion. Moreover, in a paper entitled “Pregnancy, Immu-
nity, Schizophrenia and Autism”, Patterson underlines 
the fact that cytokines are not the only possible bridge 
from a mother’s infection to the developing fetal brain; 
indeed, during infections, changes occur in other soluble 
immunological substances, such as corticosteroids for 
instance. Furthermore, Patterson highlights the need to 
consider genetic components and how they act to mod-
ulate brain development [86]. In addition, Short et al. 
have demonstrated that babies born to rhesus monkeys 
infected with the flu virus during pregnancy have both 
significantly smaller brains than normal and other brain 
abnormalities seen in schizophrenia [87]. These results 
are consistent with the findings of Mednick et al. [88], 
who reported an increased risk of schizophrenia in per-
sons who had been in the fetal stage in 1957 – the time 
of the pandemic known as the “Asian” pandemic – and 
with the study by Byrne et al. [89]. Vaccination should 
therefore be considered a valuable tool, particularly dur-
ing pregnancy, in that it may also help to prevent schizo-
phrenia. Indeed, the CDC recommends influenza vac-
cination in any period of gestation [90].
Transverse myelitis
Concerning transverse myelitis, a number of papers have 
reported the occurrence of this severe adverse event after 
the administration of different types of vaccines (against 
measles, varicella, influenza, hepatitis, etc.)  [91-97]. 
However, these are only case reports which do not estab-
lish a causal link, as pointed out by the IOM with regard 
to vaccines against: MR / MMR, chickenpox, influenza, 
hepatitis A, hepatitis B, papillomavirus, diphtheria, teta-
nus, pertussis, and meningococcus [31].
Discussion
Since the 1970s, fears concerning vaccinations have pe-
riodically flared among populations. These fears have 
arisen from reports of individual cases of adverse events 
or from studies on groups of patients suffering from se-
rious diseases, such as autism, mental retardation, epi-
lepsy, etc.
In truth, vaccinations may elicit serious adverse reac-
tions, such as anaphylactic shock, which is actually a 
very rare occurrence  [98]. However, each vaccination 
centre must be appropriately equipped to treat this type 
of event promptly. It cannot be denied that the old vac-
cines against rabies and smallpox and the oral polio vac-
cine could cause serious, albeit rare, neurological reac-
tions. However, by the early twentieth century enormous 
progress had been made in terms of the design, devel-
opment and quality control of vaccines. Thus, in most 
cases, only mild and transient side effects can now be 
expected after vaccination. They are scientifically and 
rationally designed to stimulate the immune system. In-
deed, vaccines stimulate a large number of cells to pro-
duce a variety of soluble substances, which interact with 
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each other in a process that enables lymphocytes and an-
tibodies to be activated, produced, balanced and stored). 
The substances that are produced during the immune-
response include compounds that induce the local symp-
toms (pain, redness and swelling) and general symptoms 
of inflammation (fever). Inflammation should therefore 
be regarded merely as the protective attempt of the or-
ganism to remove harmful stimuli, and is achieved by 
the increased movement of plasma and leukocytes (es-
pecially granulocytes) to initiate healing [99]. 
Unfortunately, however, a severe neurological disease 
may arise simply by chance after the administration of a 
vaccine. This has prompted speculation that such diseases 
may actually be caused by the vaccination, not least be-
cause the true causes of many neurological diseases are 
largely unknown. It is understandable that neurological 
disorders arouse fear. Indeed, they can cause severe dis-
ability, seriously impairing the individual’s quality of life 
(dependence on others, inability to carry out intimate per-
sonal care, sexual difficulty, memory loss and impaired 
judgment, prejudice and social stigma, etc.). Such consid-
erations have fuelled anti-vaccination associations, as in 
the cases of MMR vaccination and autism and influenza 
vaccination and Alzheimer’s disease. On these issues, the 
mass media have often adopted a somewhat “sensational” 
stance, which has impacted negatively on public health in 
general and on the health of children in particular. In real-
ity, it should be borne in mind that the case reports pub-
lished in the literature have almost always shown only a 
temporal association between vaccination and neurologi-
cal events, while controlled studies have either excluded 
such associations, as in the case of the MMR vaccine and 
autism, or have been unable to establish a causal link be-
tween the vaccine and severe neurological reactions, such 
as in the case of diphtheria, tetanus and pertussis vaccines 
and optic neuritis.
In conclusion, we can say, with little risk of error, that 
the association between modern vaccinations and seri-
ous neurological disorders is a true “urban myth”.
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